Skip to main content
Matthew Bott, MD, Thoracic Surgery, New York, NY

MatthewJosephBottMD

Thoracic Surgery New York, NY

Cardiovascular Surgery

Physician

Overview of Dr. Bott

Dr. Matthew Bott is a thoracic surgeon in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from University of Virginia School of Medicine and has been in practice 12 years. He is one of 39 doctors at Memorial Sloan Kettering Cancer Center and one of 7 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Thoracic Surgery. He has more than 100 publications and over 500 citings.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Thoracic Surgery, 2013 - 2015
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2005 - 2013
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 2005

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NJ State Medical License
    NJ State Medical License 2019 - 2025
  • NY State Medical License
    NY State Medical License 2007 - 2025
  • MO State Medical License
    MO State Medical License 2013 - 2015
  • American Board of Surgery Surgery
  • American Board of Thoracic Surgery Thoracic and Cardiac Surgery

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma  
    Matthew J Bott, Daniela Molena, Prasad S Adusumilli, JAMA Surgery

Press Mentions

  • Surgical Outcomes After Neoadjuvant Chemotherapy plus Nivolumab with and Without Ipilimumab in Patients with Non-Small Cell Lung Cancer
    Surgical Outcomes After Neoadjuvant Chemotherapy plus Nivolumab with and Without Ipilimumab in Patients with Non-Small Cell Lung CancerMay 8th, 2023
  • Treatment of Esophageal/Gastroesophageal Junction Adenocarcinoma in Patients with History of Prior Bariatric Surgery
    Treatment of Esophageal/Gastroesophageal Junction Adenocarcinoma in Patients with History of Prior Bariatric SurgeryMay 7th, 2023
  • Kicking Pancreatic Cancer’s Butt
    Kicking Pancreatic Cancer’s ButtSeptember 5th, 2019

Professional Memberships